drugset / Trial / NCT01155219

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.

NCT01155219

Phase 4 Completed 150 enrolled Laboratoires Thea
RandomizedParallel-groupOpen-labelTreatment

Summary

This phase IV study aims to assess the safety and the efficacy in intra ocular pressure of Geltim LP® 1 mg/g (0.1% unpreserved timolol maleate gel) in glaucomatous patients initially treated and stabilised by monotherapy of Xalatan® with ocular objective signs of intolerance to prostaglandin eye drops.

Timeline

Start
2008-07
Primary completion
2009-07
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanaprost Unknown Other
Subject Timolol Other / unclassified 1 unknown Other

Indications